- Advertisement -
Between 2012 and 2017, 62 babies and toddlers were treated with a genetic therapy for severe combined immunodeficiency, known colloquially as the “Bubble Boy disease.”
Between 2012 and 2017, 62 babies and toddlers were treated with a genetic therapy for severe combined immunodeficiency, known colloquially as the “Bubble Boy disease.”